A Novel Hydrogen Sulfide Prodrug, <scp>SG</scp>1002, Promotes Hydrogen Sulfide and Nitric Oxide Bioavailability in Heart Failure Patients

Summary Recent studies demonstrate robust molecular cross talk and signaling between hydrogen sulfide (H 2 S) and nitric oxide ( NO ). Heart failure ( HF ) patients are deficient in both H 2 S and NO , two molecules that are critical for cardiovascular homeostasis. A phase I clinical trial of a nove...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: David J. Polhemus, Zhen Li, Christopher B. Pattillo, Gabriel Gojon, Tony Giordano, Henry Krum
Formato: Artigo
Lenguaje:inglés
Publicado: 2015
Acceso en línea:https://doi.org/10.1111/1755-5922.12128
https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/1755-5922.12128
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!